On September 6, 2022 Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, reported that management will present at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12 through September 14, 2022 (Press release, Protara Therapeutics, SEP 6, 2022, View Source [SID1234619068]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The prerecorded presentation will become available on-demand on Monday, September 12, 2022 at 7:00 a.m. ET and can be accessed by visiting the Events and Presentations section of the Company’s website: View Source The webcast will be archived for 90 days following the presentation.